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Abstract 
 
Therapy of colon cancer by using 5-FU often causes problems of resistance. This 
encourages the development of co-chemotherapy agent. One of the compounds that could 
potentially be used as a co-chemotherapy agent is hesperidin. This study was conducted to 
determine the cytotoxic effects of hesperidin, 5-FU and the combination of them, as well as 
apoptosis induction in colon cancer cells WiDr. Cytotoxic effect of hesperidin, 5-FU, and its 
combination were observed using MTT assay. Observation of apoptosis was done by double 
staining method using ethidium bromide-acridin orange. Until 48 hours incubation, hesperidin 
showed no cytotoxic effects. Cytotoxic effects of 5-FU was observed after 48 hours with the 
IC50 value of 422 µM. However, hesperidin improved the cytotoxic effects of 5-FU at 48 hour 
incubation. Either single treatment of hesperidin 200µM or 5-FU 1500 µM did not trigger 
apoptosis, but combination of them led to the emergence of signs of apoptosis. Based on this 
study,it can be concluded thathesperidin is potential to be developed as a co-chemotherapy 
agent of 5-FU on colon cancer but still need further study on its molecular mechanisms. 
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INTRODUCTION 
 
The alteration of life style, dietary, 
change and lower physical activity increase the 
incidence of colon cancer (Center et al., 2009). 
Dharmais Hospital reported that colon cancer 
was included in big ten of cancer in Indonesia 
(Medical Record of Dharmais Hospital, 2009). 
Thus, the best therapy was needed to improve 
the quality of life and prevent mortality of 
colon cancer patient. Chemotherapeutic agent 
5-fluorouracil (5-FU) isthe first choice for the 
treatment of colon cancer (Priestman, 2008). 
This chemotherapeutic agent acts as 
competitive substrate for the enzyme 
thymidylate synthetase (TS). Thymidylate 
synthetase is an enzyme which 
synthesizedeoxythymidine-5'-monophosphate 
(dTMP) as anecessary precursor in the 
synthesisof DNA (Matuo et al., 2008). 
Resistanceof cancer cells to5-FU caused 
treatment using 5-FU remains ineffective 
(Meyerhardt and Mayer, 2005; Giovannetti et 
al., 2007). Therefore, one of the strategies to 
improve the effectiveness of chemotherapy 
agent is by using the chemopreventive agent 
(Priestman, 2008). 
Hesperidin is one of flavonoid contained 
in citrus peel and potential to be used as a 
chemopreventive agent in vitro and in vivo. 
Hesperidin showed cytotoxic effects on Caco 2 
cells, CEM/ADR5000, and CCRF-CEM with 
IC50 195, 230, and 95 μM respectively (El-
Readiet al., 2009). Melanogenesis in mouse 
melanoma cells could be inhibited by 
hesperidin through tyrosinasediphenolase with 
IC50 16.08 μM (Zhang et al., 2007). Hesperidin 
also inhibits the proliferation of MCF-7 cells 
which were transfected with green fluorescent 
protein (GFP)/alpha-tubulin (Lee et al., 2009). 
Hesperidin inhibits the proliferation of lung 
cancer cells in mice induced benzo[a]pyrene 
(Kamaraj et al., 2008). Hesperidin induces 
apoptosis on colon cancer cells through 
decrease in protein expression of Bcl-2 and 
procaspase-3, increased expression of Bax 
protein, and activation of caspase-3 (Park et al., 
2008). Therefore, hesperidin could be used as a 
co-chemoterapeutic agent on colon cancer. 
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This study was conducted to develop 
agents which could enhance the effectiveness of 
5-FU in the treatment of colon cancer. This 
study was performed in vitro using WiDr cells. 
WiDrcells showed low sensitivity to 5-FU (Liu 
et al., 2006). Therefore, it is interesting to 
examine whether the sensitivity of WiDr cancer 
cells to 5-FU could be enhanced by hesperidin 
as co-chemotherapeutic agent. 
 
MATERIALS AND METHODS 
 
Cells Culture 
WiDr cells were obtained from Cancer 
Chemoprevention Research Center, Faculty of 
Pharmacy, Universitas Gadjah Mada.  Cells 
were grown in Roswell Park Memorial Institute 
(RPMI) 1640 (Gibco) with 10% Fetal Bovine 
Serum (Gibco) and 1% Penicillin-
Streptomycin (Gibco) at 37°C in a humidified 
atmosphere of 5% CO2/95% air. 
 
Cell Viability Assay 
Cell viability assays were performed 
using MTT assay. WiDr cells were seeded at a 
density of 5x10
3
 cells/well and allowed to 
attach for 24h. One day after initial seeding, 
cells were treated with either various 
concentrations of hesperidin (Sigma) alone, 5-
FU alone and their combination. After 48h of 
incubation, culture medium was removed and 
cells were washed with PBS (Sigma). Then, 
cells were added with 100 µL MTT (Sigma) 5 
mg/mL diluted with culture medium in each 
well for 4-6h. Stopper reagent was added after 
formazan formation prior to MTT reduction and 
incubated for one night in dark room. The 
absorbance of each well was measured using 
ELISA reader at 595 nm (Bio-Rad). The IC50 
was determined using Excell MS Office 2007 
and probit analysis (SPSS 11.5). 
 
 
Apoptosis Detection 
 Apoptosis was detected using acrydine 
orange-ethidium bromide staining (AO/EB 
double staining). WiDr cells (5x10
4
cells/well) 
were seeded on coverslips in 24-well plates 
until 50-60% confluent. Cells were then 
incubated with hesperidin alone, 5-FU alone 
and their combination for 24h. Culture medium 
was removed and cells were washed with PBS. 
Coverslips were placed into object-glass and 
added with 10 µL 1X working solution 
acrydine orange (Sigma)-ethidium bromide 
(Sigma), then were observed under 
fluoroscence microscopy (Zeiss MC 80). 
Apoptotic cells which had lost their membrane 
integrity was appeared as orange cells and 
showed morphological features of apoptosis. 
Cells were identified as apoptotic cells based on 
specific morphological criteria, including 
condensation and fragmentation of chromatin, 
also formation of apoptotic bodies. 
 
RESULTS AND DISCUSSION 
 
Effect of Hesperidin and 5-Fu on WiDr 
Cell Viability 
Cell viability assay was done to 
determine the inhibitory concentration (IC50) of 
hesperidin alone, 5-FU alone and their 
combination on WiDr cells.  Hesperidin did not 
show cytotoxic effect even after 48 hour 
incubation (Fig.1), while 5-FU had the IC50 
values of 422 µM after 48 hour of treatment 
(Fig.2). However, hesperidin increased 
cytotoxic effect of 5-FU. Cell viability caused 
by combination of 5-FU 500 µMand hesperidin 
200 µM was lower than cell viability even 
caused by even with highest concentration of 5-
FU solely (1500 µM) (Fig.3). Combination of 
hesperidin and 5-FU also altered morphology of 
WiDr cells. 
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Figure 1. Effect of hesperidin on WiDr Cell’sViability.WiDr cells with density (5x103) were treated 
by hesperidin (5-200 µM) and incubated for 48 hours. Cells viability were obtained from 
the conversion of absorbance values of formazan that formed by MTT treatment as 
described in the materials and method. Incubation of hesperidin for 48 hour did not 
show cytotoxic effect at WiDr cell (A), compared to cell control (B) alteration of 
morphology was shown at concentration of hesperidin of 50 µM (C) and 100 µM (D), 200 
µM  (E). Description:      normal WiDr cells,              cells undergoing 
morphological changes. 
 
    
 
 
Figure 2. Effect of 5-FU on WiDr cell Viability. WiDr cells with density (5x103) were treated by 5-
FU (10-2500 µM) and incubated for 48 hours. Cells viability were obtained from the 
conversion of absorbance values of formazan that formed by MTT treatment as described 
in the research procedure. Incubation of 5-FU for 48 hour lower the cell viability of WiDr 
cell (A), if we compared to cell control (B) alteration of morphology was shown at 
concentration of hesperidin of 500 µM (C) and 1000 µM (D), 2500 µM (E). Description: 
 normal WiDr cells, cells undergoing morphological changes. 
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Figure 3. Effects of combination of hesperidin and 5-FU on WiDr cell viability. WiDr cells with 
density (5x103) were treated by 5-FU (500 µM), hesperidin (10, 50, 100, 200 µM) and 
combination of both incubated for 48 hours. Cells viability were obtained from the 
conversion of absorbance values of formazan that formed by MTT treatment as described 
in the research procedure. Hesperidin was increase the cytotoxic effect of 5-FU (A). The 
morphology observation was using inverted microscope at magnification 400x. Hesperidin 
200 µM (D), 5-FU 500 µM (C) or combination of both agent (E) produce the alteration of 
cell morphology.Description: normal WiDr cells, cells undergoing morphological 
changes. 
 
Effects of Hesperidin and 5-FU on 
Apoptosis. 
Both of hesperidin and 5-FU were not 
able to induce apoptosis at single treatment of 
5-FU 1500 µM or hesperidin 200 µM. 
Interestingly, combination of hesperidin and 5-
FU was able to induce apoptosis. The green 
fluorescence indicates the viable cells while the 
orange-red fluorescence indicates the death 
cells. Apoptotic cells were indicated by 
occurrence of chromatin condensation and the 
orange-red apoptotic bodies. 
 
    
 
 
Figure 4. Effect of Hesperidin and 5-FU on apoptosis.Cells were treated with (A) control cells 
(untreated), (B) 5-FU 1500 µM, (C) hesperidin 200 µM, and (D) combination of 5-FU 1500 
µM and hesperidin 200 µM at incubation time 24 h. Cells was stained with acrydine orange-
ethidium bromide and observed under  fluorosence microscope with 100x magnification. 
Yellow arrow (      ) indicating apoptotic cells, while white arrow (      ) indicating viable 
cells. 
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The results showed that hesperidin 
treatment up to 48 hours incubation showed no 
cytotoxic activity and apoptosis induction 
against WiDr cells. This result is similar with 
study conducted by Lee et al. (2009) which 
reported that treatment of hesperidin 100 µM 
for 72 hours on MC-7-GF-Tubulin showed no 
cytotoxic effects but only antiproliferative 
effect. WiDr cells undergo morphological 
changes due to treatment hesperidin. Cells 
became larger after treated with hesperidin. 
This may be due to cell cycle arrest caused by 
hesperidin. Therefore, further research needs to 
be conducted to observe the effects of 
hesperidin on cell cycle arrest. 
Chemotherapeutic agent is expected to 
induce apoptosis of cancer cells. Single 
treatment of 5-FU for 48 hours were able to 
demonstrate cytotoxic effect. Long term use of 
5-FU caused cancer cells resistance to apoptosis 
induction (Violette et al., 2002). 
Chemotherapeutic agent 5-FU induces IκBα 
degradation thus increasing the activation of 
NF-κB and increases the translocation and 
binding of NF-κB to DNA (Wang et al., 2003; 
Voboril et al., 2004). NF-κB activation will 
further increase the expression of Bcl-2 and 
Bcl-XL which are antiapoptosis protein 
(Ruddon, 2007). Cytotoxic activity of 
hesperidin combination with 5-FU after 48 
hours showed a stronger cytotoxic effect as well 
as induce apoptosis than single treatment of 5-
FU. This results demonstrated the ability of 
hesperidin in increasing the sensitivity of 
cancer cells to 5-FU. 
One possibility according to hesperidin 
activity is hesperidin increases 5-FU transport 
into the cells. Hesperidin treatment caused 
changes in cell morphology, including changes 
in the cell membrane that may occur due to 
membrane fluidity alteration. Membrane 
fluidity influence passive transport of a 
compound and affects the number of molecules 
compound that enter the cells (Hendrich and 
Michalak, 2003). Change in membrane fluidity 
is likely to cause 5 - FU is not only transported 
by specific carrier by active transport but also 
through passive transport. This phenomenon 
increase the 5-FU influx, thereby increasing the 
effectiveness of 5-FU against WiDr cells. 
Research done by Callaghan et al. (1993) stated 
that interference with membrane fluidity may 
increase the amount of drug entry into the cell, 
thereby increasing the cell’s sensitivity. 
Nevertheless, further research on hesperidin 
effect against changes in membrane fluidity and 
increase transport of 5-FU into the cells still 
needs to be done. 
Based on these results, the cytotoxic 
effect of 5-FU could be enhanced with the use 
of hesperidin as co-chemotherapeutic agent. 
Hesperidin also increased the apoptosis 
induction together with the use of 5-FU. The 
use of hesperidin as combination agents may 
also reduce the dose of 5-FU and expected to 
reduce the risk of side effects of 5-FU in colon 
cancer chemotherapy.  
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